A controlled release system composed of mesoporous silica
nanoparticles
with covalently bound dipalmitoyl moieties supporting phosphorylated
lipids has been successfully synthesized and characterized. This MSN
system demonstrates controlled release of fluorescein molecules under
disulfide reducing conditions. Flow cytometry analyses confirm increased
biocompatibility of the resulting lipid bilayer MSNs (LB-MSNs) from
nonfunctional MSNs. Fluorescently labeled LB-MSNs are examined via
confocal fluorescent microscopy ex vivo and were
found to enter both normal and cancer cell lines. The LB-MSNs presented
here have potential to be used as rapid and diverse functionalized,
stable liposome analogues for drug delivery.